FDA Clears Cepheid's TB Test | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Thursday that its Xpert MTB/RIF test has received de novo 510(k) clearance from the US Food and Drug Administration for marketing in the US.

The test is available for immediate shipment in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."